Autologous Stem/Stromal Cells in Neurological Disorders and Disease | MicrobiomeTrials← Back to trialsNCT03297177
Autologous Stem/Stromal Cells in Neurological Disorders and Disease
UNKNOWNNAINTERVENTIONAL
Trial Details
Start: 2020-01-01Est. Completion: 2023-01-01
Enrollment target: 300 participants Locations- Regeneris Medical Inc, North Attleboro, Massachusetts, United States
- Regeneris Medical, North Attleboro, Massachusetts, United States
Other microbiome trials you might be interested in
Frontotemporal Dementia
This study is testing a new treatment for Frontotemporal Dementia (FTD) - a progressive brain disease that affects perso…
Multiple LocationsEst. completion Oct 31, 2027
Alzheimer Disease
This study will primarily investigate the safety and secondarily the effect and applicability of Transcranial Pulse Wave…
Potsdam, GermanyEst. completion Oct 1, 2026
Moderate to Severe Alzheimer's Disease
The objective of this study is to evaluate the safety and efficacy of GV1001 administered subcutaneously in patients wit…
Multiple LocationsEst. completion Jan 2028